The National Law Journal


The big wins have piled up recently for Winston & Strawn's intellectual property team. In April, Winston's James Hurst won a 9-0 ruling for client Caraco Pharmaceutical Laboratories Ltd. at the U.S. Supreme Court in a case that opens a new pathway for generic drug companies to challenge the accuracy of patent information name-brand companies give to the U.S. Food and Drug Administration. The defeat of Danish name-brand pharmaceutical firm Novo Nordisk A/S was just one of a string of wins for generic drug companies.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202551828191

Thank you!

This article's comments will be reviewed.